Urology therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... the therapeutics under development for Tuberous Sclerosis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological......" | 30-Apr-2021 | $2000 | |
Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021By Global Markets Direct "...... >
The report provides comprehensive information on the therapeutics under development for Primary Hyperoxaluria, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. ......" | 30-Apr-2021 | $2000 | |
Kennedy's Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... Bulbar Muscular Atrophy) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Kennedy's Disease (Spinal and Bulbar Muscular Atrophy), complete with analysis by Stage of Development,......" | 30-Apr-2021 | $2000 | |
Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... mprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also co......" | 30-Apr-2021 | $2000 | |
Charcot-Marie-Tooth Disease Type I A (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... r />
The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type I A, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) a......" | 30-Apr-2021 | $2000 | |
Tay-Sachs Disease (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... therapeutics under development for Tay-Sachs Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Act......" | 30-Apr-2021 | $2000 | |
Genito Urinary System And Sex Hormones (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021By Global Markets Direct "...... em And Sex Hormones pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Genito Urinary System And Sex Hormones, complete with analysis by Stage of Development, Drug Target, Mechanis......" | 30-Apr-2021 | $2000 | |
Chronic Granulomatous Disease (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... des comprehensive information on the therapeutics under development for Chronic Granulomatous Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report......" | 30-Apr-2021 | $2000 | |
Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... e I (Arginosuccinate Synthetase Deficiency) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Citrullinemia Type I (Arginosuccinate Synthetase Deficiency), complete with analysis ......" | 30-Apr-2021 | $2000 | |
Cystinuria (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... evelopment for Cystinuria, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its......" | 30-Apr-2021 | $2000 | |
|